Have you been diagnosed with Asthma?
You are invited to take part in this research project.
The research project is testing the effectiveness and safety of a potential new triple therapy medicine to better manage and treat Asthma. Please complete the following survey to express interest in participating in the above-mentioned trial.
Please be aware that completion of the survey does not guarantee entry into the trial.
Full title: A Phase III, randomized, double-blind, active controlled, parallel group study, comparing the efficacy, safety and tolerability of the fixed dose combination FF/UMEC/VI with the fixed dose dual combination of FF/VI, administered once-daily via a dry powder inhaler in subjects with inadequately controlled asthma.
Ethics approval – Bellberry Limited
If you experience difficulty completing the survey please email email@example.com